Contrarily, the current study showed the different incidents of irAEs among cancer type treated with anti‐PD‐1 monotherapy such as the highest incidences of irAEs was 62.3% in melanoma, and the lowest incidence of irAEs was 29.3% in gastric cancer (Table S1). Here, PDCD1 is linked to melanoma.